IP Library Granted Patent US 10,603,062
Granted Patent B2
US 10,603,062 · App. 16/406,983 · Granted Mar 31, 2020

Pericardial modification systems and methods for heart failure treatment

Inventors: Samuel J. Asirvatham (Rochester, MN); Barry A. Borlaug (Rochester, MN); Vojtech Melenovsky (Prague, CZ)
Assignee: Mayo Foundation for Medical Education and Research
A61B17/295A61B17/29A61B17/3201A61B17/3209A61B17/320016A61B17/32053A61B18/1445A61B18/1492A61B2017/003A61B2017/00225A61B2017/00247A61B2017/00318A61B2017/22039A61B2017/2906A61B2018/00595A61B2018/00839
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,603,062
App. No.
16/406,983
Granted
Mar 31, 2020
Kind
B2
Abstract

Pericardial modification devices and methods can be used for the treatment of heart conditions. For example, this document describes devices and methods for treating heart failure with preserved ejection fraction, including diastolic heart failure, by performing a pericardial modification procedure. In one example embodiment, a method for treating diastolic heart failure includes creating an opening in a patient's pericardial tissue, or removing a portion of the patient's pericardial tissue. The creation of the opening or the removing of the pericardial tissue reduces pressure exerted by the pericardial tissue on the patient's heart. The pericardial modification procedures are performed while avoiding trauma to the epicardial surface of heart as well as the phrenic nerves.

Claims (11)

1. A method for treating diastolic heart failure of a patient, the method comprising:

creating an opening in a parietal layer, and only in said parietal layer, by removing a portion of said parietal layer of a pericardial tissue of said patient, wherein creating said opening reduces pressure exerted by said pericardial tissue on a heart of said patient.

2. The method of claim 1 , further comprising probing to ascertain a location of a phrenic nerve.

3. The method of claim 1 , wherein said opening in said pericardial tissue of said patient is created using a transcatheter device.

4. The method of claim 3 , wherein said transcatheter device includes one or more electrocautery electrodes.

5. The method of claim 1 , further comprising using a grasping device to manipulate said pericardial tissue of said patient.

6. The method of claim 1 , wherein said opening in said pericardial tissue of said patient is an incision.

7. The method of claim 1 , further comprising inserting a guidewire between said pericardial tissue and a surface of said heart of said patient.

8. The method of claim 7 , further comprising advancing a pericardial modification device over said guidewire.

9. The method of claim 8 , wherein said pericardial modification device is configured to shear said pericardial tissue of said patient.

10. The method of claim 8 , wherein said pericardial modification device is configured to cauterize said pericardial tissue of said patient.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2019
From: ASIRVATHAM, SAMUEL J.; BORLAUG, BARRY A.; MELENOVSKY, VOJTECH
To: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 051130/0573 →
Continuity (4)
Continuation 14773487
Provisional Application 61798382 · Mar 15, 2013
Provisional Application 61776483 · Mar 11, 2013
Related Publication 20190262019A1 · Aug 29, 2019
Cited By (1)
US 12,414,789